CClinicalTrials.gg
CompletedNCT06261619Updated Jul 21, 2026

Superiority Trial Between Sotair® Device Attached to Manual Resuscitator Versus Ventilation Alone

An interventional study of Adult Sotair Device in Airway Management and Respiration, Artificial, sponsored by Rhode Island Hospital. Completed at 1 site in United States. Open to participants aged 18 Years to 80 Years. Per ClinicalTrials.gov, last updated 2026-07-21.

Sponsored by Rhode Island Hospital · Not applicable, Interventional, and Supportive care

From the registry’s dates

  • Primary completion was Mar 2025, 1 year 6 months ago, and no results have been posted to the registry.
Phase
Not applicable
Study type
Interventional
Enrollment
30
Allocation
Randomized
Ages
18 Years to 80 Years
Sex
All
01

Study summary

Effective respiratory ventilation is achieved by moving the right amount of air to and out of the lungs while keeping the pressures at a safe level. A disposable safety device, Adult Sotair®, was created to improve manual ventilation delivery. In this superiority study, the investigators will perform two-group cross over randomized design to test the superiority of the Adult Sotair® device compared to manual ventilation alone.

Read the detailed description

Poor manual ventilation technique is a well-documented problem which occurs irrespective of a provider's qualifications or experience. A disposable safety device, Adult Sotair®, was created to improve manual ventilation delivery among providers. The device is attached to a manual resuscitator and employs a flow limiting valve mechanism to minimize excessive pressure in the airway system without venting air by capping peak flow rates at 55 L/min. For an average adult with normal lung compliance and resistance, this corresponds to a maximum airway pressure of approximately 20 cmH2O which minimizes air entry into the stomach. In this superiority study (margin 7.5 cm H20), the investigators will use a two-group cross over randomized design to test the superiority of the Adult Sotair® device compared to manual ventilation alone with respect to airway pressure.

02

Conditions studied

  • Airway Management
  • Respiration, Artificial

Keywords

  • Mechanical Ventilation
  • General Anesthesia
  • Bag Mask Ventilation
  • Adult Sotair Device
03

In context

Respiratory Aspiration

1,092 studies on the registry are indexed under Respiratory Aspiration; 216 are open to participants now.

This study's enrollment of 30 is below the median of 42 across 881 interventional studies indexed under Respiratory Aspiration.

Browse Respiratory Aspiration studies →

Lead sponsor

Rhode Island Hospital is the lead sponsor of 187 studies on the registry; 37 are open to participants now.

Of its 11 completed or terminated interventional studies of FDA-regulated products, 2 (18%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 80 Years
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • Adult patients who are scheduled for non-emergency surgery with general anesthesia (w/artificial airway) at Rhode Island Hospital.
  • American Society Of Anesthesiologists Physical Status 1 and 2

Exclusion criteria

Exclusion Criteria:

  • American Society of Anesthesiologists Physical Status >3 (e.g. respiratory disease)
  • Oropharyngeal or facial pathology
05

Study design

Phase
Not applicable
Primary purpose
Supportive care
Allocation
Randomized
Intervention model
Crossover assignment
Masking
Single (Participant)
Enrollment
30 participants (actual)

Study arms

  • Active comparator
    Bag mask ventilation with Adult Sotair device

    The anesthesia provider will manually bag ventilate with the Adult Sotair® device for 3 minutes with an average respiratory rate of 12 breaths per minute with a deep breath every 30 seconds.

    Device: Adult Sotair Device

  • No intervention
    Bag mask ventilation

    The anesthesia provider will manually bag ventilate for 3 minutes with an average respiratory rate of 12 breaths per minute with a deep breath every 30 seconds.

Interventions

  • DeviceAdult Sotair Device

    Adult Sotair® device employs a flow limiting valve mechanism.

    Also known as: Sotair, SafeBVM

06

What researchers measure

Primary outcomes

  1. Peak airway pressure

    Mean of the maximum peak airway pressures expressed in cm H2O

    Time frame: Recorded every thirty seconds for a total duration of 3 minutes for each arm of the study

Secondary outcomes

  1. Tidal volume

    The amount of air that moves to or out of the lungs with each respiratory cycle. Measured in mL. Mean of the maximum tidal volumes every 30 seconds.

    Time frame: Recorded every thirty seconds for a total duration of 3 minutes for each arm of the study

  2. Airflow

    Represents the volume of air moved per unit of time during inspiration and expiration. Measured (L/min)

    Time frame: Recorded every thirty seconds for a total duration of 3 minutes for each arm of the study

07

Study locations

1 site
  • Rhode Island Hospital
    Providence, Rhode Island 02903, United States
08

References and documents

Publications

  • Fogarty M, Kuck K, Orr J, Sakata D. A comparison of controlled ventilation with a noninvasive ventilator versus traditional mask ventilation. J Clin Monit Comput. 2020 Aug;34(4):771-777. doi: 10.1007/s10877-019-00365-1. Epub 2019 Jul 23. PubMed 31338661 ↗
  • von Goedecke A, Bowden K, Wenzel V, Keller C, Gabrielli A. Effects of decreasing inspiratory times during simulated bag-valve-mask ventilation. Resuscitation. 2005 Mar;64(3):321-5. doi: 10.1016/j.resuscitation.2004.09.003. PubMed 15733761 ↗
  • Culbreth RE, Gardenhire DS. Manual bag valve mask ventilation performance among respiratory therapists. Heart Lung. 2021 May-Jun;50(3):471-475. doi: 10.1016/j.hrtlng.2020.10.012. Epub 2020 Nov 1. PubMed 33138977 ↗

Individual participant data

Plan to share: Yes — The IPD that underlie the results in a publication will be shared with other researchers.

Supporting information: Sap

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jul 21, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06261619
Lead sponsor
Rhode Island Hospital
Responsible party
Mark Kendall (Director of Clinical Research, Rhode Island Hospital) — Principal investigator
First posted
Feb 15, 2024
Start date
May 9, 2024
Primary completion
Mar 18, 2025
Completion
Mar 18, 2025
Last update
Jul 21, 2026

Study contacts

Mark Kendall, MD
principal investigator · Rhode Island Hospital

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
Yes
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Jul 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion